| pubmed-article:7597314 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:7597314 | lifeskim:mentions | umls-concept:C0035647 | lld:lifeskim |
| pubmed-article:7597314 | lifeskim:mentions | umls-concept:C0041740 | lld:lifeskim |
| pubmed-article:7597314 | lifeskim:mentions | umls-concept:C0151779 | lld:lifeskim |
| pubmed-article:7597314 | lifeskim:mentions | umls-concept:C0039082 | lld:lifeskim |
| pubmed-article:7597314 | lifeskim:mentions | umls-concept:C0596545 | lld:lifeskim |
| pubmed-article:7597314 | lifeskim:mentions | umls-concept:C0282441 | lld:lifeskim |
| pubmed-article:7597314 | lifeskim:mentions | umls-concept:C0027976 | lld:lifeskim |
| pubmed-article:7597314 | pubmed:dateCreated | 1995-8-3 | lld:pubmed |
| pubmed-article:7597314 | pubmed:abstractText | The presence of atypical moles (AM) is considered to be a marker for an increased risk of developing cutaneous malignant melanoma (MM). The extent to which individuals with the atypical-mole syndrome (AMS) are at risk for developing MM is unknown. We present a review of the world literature and of our experience at New York University. We conclude that the presence of AMS in Caucasians significantly increases the risk of developing MM, regardless of geographic location. A further increase in MM risk is noted if there is a personal and/or family history of MM. | lld:pubmed |
| pubmed-article:7597314 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7597314 | pubmed:language | eng | lld:pubmed |
| pubmed-article:7597314 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7597314 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:7597314 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:7597314 | pubmed:issn | 0080-0015 | lld:pubmed |
| pubmed-article:7597314 | pubmed:author | pubmed-author:KopfA WAW | lld:pubmed |
| pubmed-article:7597314 | pubmed:author | pubmed-author:SladeJJ | lld:pubmed |
| pubmed-article:7597314 | pubmed:author | pubmed-author:RigelD SDS | lld:pubmed |
| pubmed-article:7597314 | pubmed:author | pubmed-author:SalopekT GTG | lld:pubmed |
| pubmed-article:7597314 | pubmed:author | pubmed-author:MarghoobA AAA | lld:pubmed |
| pubmed-article:7597314 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:7597314 | pubmed:volume | 139 | lld:pubmed |
| pubmed-article:7597314 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:7597314 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:7597314 | pubmed:pagination | 87-104 | lld:pubmed |
| pubmed-article:7597314 | pubmed:dateRevised | 2008-2-13 | lld:pubmed |
| pubmed-article:7597314 | pubmed:meshHeading | pubmed-meshheading:7597314-... | lld:pubmed |
| pubmed-article:7597314 | pubmed:meshHeading | pubmed-meshheading:7597314-... | lld:pubmed |
| pubmed-article:7597314 | pubmed:meshHeading | pubmed-meshheading:7597314-... | lld:pubmed |
| pubmed-article:7597314 | pubmed:meshHeading | pubmed-meshheading:7597314-... | lld:pubmed |
| pubmed-article:7597314 | pubmed:meshHeading | pubmed-meshheading:7597314-... | lld:pubmed |
| pubmed-article:7597314 | pubmed:meshHeading | pubmed-meshheading:7597314-... | lld:pubmed |
| pubmed-article:7597314 | pubmed:meshHeading | pubmed-meshheading:7597314-... | lld:pubmed |
| pubmed-article:7597314 | pubmed:meshHeading | pubmed-meshheading:7597314-... | lld:pubmed |
| pubmed-article:7597314 | pubmed:meshHeading | pubmed-meshheading:7597314-... | lld:pubmed |
| pubmed-article:7597314 | pubmed:meshHeading | pubmed-meshheading:7597314-... | lld:pubmed |
| pubmed-article:7597314 | pubmed:meshHeading | pubmed-meshheading:7597314-... | lld:pubmed |
| pubmed-article:7597314 | pubmed:meshHeading | pubmed-meshheading:7597314-... | lld:pubmed |
| pubmed-article:7597314 | pubmed:meshHeading | pubmed-meshheading:7597314-... | lld:pubmed |
| pubmed-article:7597314 | pubmed:meshHeading | pubmed-meshheading:7597314-... | lld:pubmed |
| pubmed-article:7597314 | pubmed:year | 1995 | lld:pubmed |
| pubmed-article:7597314 | pubmed:articleTitle | Risk of developing cutaneous malignant melanoma in atypical-mole syndrome: New York University experience and literature review. | lld:pubmed |
| pubmed-article:7597314 | pubmed:affiliation | Ronald O. Perelman Department of Dermatology, New York University School of Medicine, NY 10016, USA. | lld:pubmed |
| pubmed-article:7597314 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:7597314 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| pubmed-article:7597314 | pubmed:publicationType | Review | lld:pubmed |
| pubmed-article:7597314 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:7597314 | lld:pubmed |
